Clinical trial
Prognostic Hemodynamic and Metabolic Profiles of Late Stage Lower Extremity Arterial Disease
NCT04143386 is registered in ClinicalTrials.gov with University of Tartu as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prognostic Hemodynamic and Metabolic Profiles of Late Stage Lower Extremity Arterial Disease
- Lead sponsor
- University of Tartu
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 4, 2019
- Completion date
- December 31, 2025
- Enrollment
- 750 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lower extremity arterial disease (fontaine stages iib-iv)